C-Stem™ is a biomimetic cell culture technology allowing for the mass-production of stem cell- derived therapies with unprecedented cell quality, while cutting manufacturing costs by 10x.
C-Stem™generates scale-independent cell culture micro-environments, allowing to progress to larger bioreactors without changing key parameters.
Safety
C-Stem™ perserves genomic integrity and yields mature cell phenotypes, thereby enhancing the safety of cellular products
C-Stem™ delivers functional microtissues, which were shown to improve graft integration and reduce time-to-effect.
Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…
👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…
J. Santamaria, Y. Gilaberte, L. Prudkin, J. Piquero-Casals 11 March 2025 Skin aging is a…